Skip to Content


Main Content

Journal of Clinical Oncology | 2023

Allogeneic hematopoietic cell transplantation improves outcome in myelodysplastic syndrome across high-risk genetic subgroups: Genetic analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study.

Versluis J, Saber W, Tsai HK, Gibson CJ, Dillon LW, Mishra A, McGuirk J, Maziarz RT, Westervelt P, Hegde P, Mukherjee D, Martens MJ, Logan B, Horowitz M, Hourigan CS, Nakamura R, Cutler C, Lindsley RC

PMID: 37607457

Related Articles

CIBMTR Study #: 1102